دانلود مقاله ISI انگلیسی شماره 128999
ترجمه فارسی عنوان مقاله

معیار آسم کودکان: توصیه های عملی برای افزایش پایدار در درمان آسم برای کودکان مبتلا به آسم ناکافی

عنوان انگلیسی
The pediatric asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma
کد مقاله سال انتشار تعداد صفحات مقاله انگلیسی
128999 2018 149 صفحه PDF
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Annals of Allergy, Asthma & Immunology, Available online 10 April 2018

پیش نمایش مقاله
پیش نمایش مقاله  معیار آسم کودکان: توصیه های عملی برای افزایش پایدار در درمان آسم برای کودکان مبتلا به آسم ناکافی

چکیده انگلیسی

Current asthma guidelines recommend a control-based approach to management involving assessment of impairment and risk followed by implementation of treatment strategies individualized according to the patient's needs and preferences. However, for children with asthma, achieving control can be elusive. While tools are available to help children (and families) track and manage day-to-day symptoms, when and how to implement a longer-term step-up in care is less clear. Furthermore, treatment is challenged by the three age groups of childhood – adolescence (12-18 years old), school age (6-11 years old), and young children (≤ 5 years old), and what works for one age group may not be the best approach for another. The Pediatric Asthma Yardstick provides an in-depth assessment of when and how to step-up therapy for the child with not well or poorly controlled asthma. Development of this tool follows the others in the Yardstick series, presenting patient profiles and step-up strategies based on current guidance documents, but modified according to newer data and the authors' combined clinical experience. The objective is to provide clinicians who treat children with asthma practical and clinically relevant recommendations for each step-up and each intervention, with the intent of helping practitioners better treat their pediatric patients with asthma, particularly those who do not always respond to recommended therapies.